-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HTD-1801 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HTD-1801 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HTD-1801 in Type 2 Diabetes Drug Details: HTD-1801 (berberine ursodeoxycholate) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bertilimumab in Allergic Conjunctivitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bertilimumab in Allergic Conjunctivitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bertilimumab in Allergic Conjunctivitis Drug Details: Bertilimumab (Ico-008, CAT-213) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HTD-1801 in Hypertriglyceridemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HTD-1801 in Hypertriglyceridemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HTD-1801 in Hypertriglyceridemia Drug Details: HTD-1801 (berberine ursodeoxycholate) is under development for the...
-
Sector Analysis
Indonesia Oil and Gas Exploration and Production Market Volumes and Forecast by Terrain, Assets and Major Companies
Indonesia Oil and Gas Exploration and Production Market Report Overview Indonesia is one of the main hydrocarbon producers and LNG exporters in Southeast Asia. The country’s oil and gas industry is dominated by natural gas production, from shallow water terrain. In 2024, production from shallow water terrain is expected to be more than 3,160mmcfd. The Indonesia oil and gas E&P market research report provides an oil and gas production outlook by assets, terrain, and major companies. The report offers key details...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PSC-01 in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PSC-01 in Osteoarthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PSC-01 in OsteoarthritisDrug Details:PSC-01 is under development for the treatment of knee osteoarthritis, back pain,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CT-0594CP CAR-T Cells in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-0594CP CAR-T Cells in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-0594CP CAR-T Cells in Refractory Multiple Myeloma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPN-60250 in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPN-60250 in Liver Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPN-60250 in Liver Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPN-60250 in Liver Diseases Drug Details: A-3907 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Constipation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Constipation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Constipation Drug Details: Aldafermin (NGM-282) is under development for the treatment...